"FDA Approves First Medication for Severe Food Allergies, Including Milk, Eggs, and Nuts"

The FDA has approved Xolair as the first medication to reduce severe allergic reactions to certain foods, marking a significant development in treating food allergies. Xolair has been used off-label for food allergies since 2014 and a study sponsored by NIH found that it increased tolerance to allergens. The drug is different from an EpiPen and is administered regularly to reduce reactions over time. Despite the approval, patients are advised to continue avoiding allergenic foods as the drug is not for emergency use. With an estimated 33 million Americans having food allergies, this approval offers hope for improved management of severe allergic reactions.